𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer

✍ Scribed by Daisuke Obinata; Ken-ichi Takayama; Tomohiko Urano; Taro Murata; Jinpei Kumagai; Tetsuya Fujimura; Kazuhiro Ikeda; Kuniko Horie-Inoue; Yukio Homma; Yasuyoshi Ouchi; Satoru Takahashi; Satoshi Inoue

Publisher
John Wiley and Sons
Year
2011
Tongue
French
Weight
522 KB
Volume
130
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The androgen receptor (AR) plays a critical role in the development and the progression of prostate cancer. Alterations in the expression of AR coregulators lead to AR hypersensitivity, which is one of the mechanisms underlying the progression of prostate cancer into a castrate‐resistant state. Octamer transcription factor 1 (Oct1) is a ubiquitous member of the POU‐homeodomain family that functions as a coregulator of AR. In our study, the contribution of Oct1 to prostate cancer development was examined. Immunocytochemistry analysis showed that Oct1 is expressed in the nuclei of LNCaP cells. siRNA‐mediated silencing of Oct1 expression inhibited LNCaP cell proliferation. Immunohistochemical analysis of Oct1 expression in tumor specimens obtained from 102 patients with prostate cancer showed a positive correlation of Oct1 immunoreactivity with a high Gleason score and AR immunoreactivity (p = 0.0042 and p < 0.0001, respectively). Moreover, patients with high immunoreactivity of Oct1 showed a low cancer‐specific survival rate, and those patients with high immunoreactivities of both Oct1 and AR exhibited poorer cancer‐specific prognosis. Multivariate hazard analysis revealed a significant correlation between high Oct1 immunoreactivity and poor cancer‐specific survival (p = 0.012). These results demonstrate that Oct1 can be a prognostic factor in prostate cancer as a coregulator of AR and may lead to the development of a new therapeutic intervention for prostate cancer.

📜 SIMILAR VOLUMES

PKC-mediated secretion of death factors
PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens
✍ Liqing Xiao; Anatilde Gonzalez-Guerrico; Marcelo G. Kazanietz 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

## Abstract Activation of PKCδ in androgen‐dependent LNCaP prostate cancer cells leads to apoptosis via the activation of p38 MAPK and JNK cascades. We have recently shown that treatment of LNCaP cells with phorbol 12‐myristate 13‐acetate (PMA) leads to a PKCδ‐mediated autocrine release of death fa

Cytotoxic sensitivity to tumor necrosis
Cytotoxic sensitivity to tumor necrosis factor-? in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin)
✍ Sintich, Sharon M.; Steinberg, Joseph; Kozlowski, James M.; Lee, Chung; Pruden, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

BACKGROUND. SGP-2 is a ubiquitous secreted glycoprotein that prevents cellular apoptosis. This study was carried out to determine the extracellular action of SGP-2 in a model of tumor necrosis factor-␣ (TNF)-induced cytotoxicity using two human prostatic cancer lines, LNCaP and PC3. These two lines

Down-regulation of Jagged-1 induces cell
Down-regulation of Jagged-1 induces cell growth inhibition and S phase arrest in prostate cancer cells
✍ Yuxiang Zhang; Zhiwei Wang; Fakhara Ahmed; Sanjeev Banerjee; Yiwei Li; Fazlul H. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 626 KB

Notch is an ancient cell signaling system that regulates cell fate specification, stem cell maintenance and initiation of differentiation in many tissues. It has been reported that Jagged-1, a Notch ligand, is significantly over expressed in metastatic prostate cancer compared to localized prostate

PDEF is a negative regulator of colon ca
PDEF is a negative regulator of colon cancer cell growth and migration
✍ Omar Moussa; David P. Turner; Ron J. Feldman; Victor I. Sementchenko; Brent D. M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

## Abstract ETS is a family of transcriptional regulators with functions in most biological processes. Dysregulated ETS factor function leads to altered expression of multiple genes that play critical roles in many of the processes required for cancer progression. While the Ets family gene, __p__ro